We are live on ! Find out more
Northern Trust

Northern Trust Portfolio holdings

AUM $757B
1-Year Est. Return 28.64%
 

Northern Trust Corporation, founded in 1889 and headquartered in Chicago, Illinois, is a prominent financial services firm specializing in wealth management, asset management, and asset servicing for high-net-worth individuals, families, and institutions. Known for its conservative and client-focused approach, it manages hundreds of billions in assets, offering trust and custody services, investment solutions, and banking products tailored to affluent clients and organizations like foundations and endowments. The company has built a reputation for reliability and discretion, serving as a custodian for a significant portion of global institutional assets while maintaining a strong presence in private banking.

This Fund
S&P 500
This Quarter Est. Return
+9.64%
1 Year Est. Return
+28.64%
3 Year Est. Return
+94.48%
5 Year Est. Return
+125.76%
10 Year Est. Return
+523.41%
AUM
$447B
AUM Growth
+$29B
Cap. Flow
-$5.27B
Cap. Flow %
-1.18%
Top 10 Hldgs %
16.98%
Holding
4,386
New
134
Increased
1,479
Reduced
2,453
Closed
124

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$431M
2
TFC icon
Truist Financial
TFC
+$346M
3
BABA icon
Alibaba
BABA
+$238M
4
NOW icon
ServiceNow
NOW
+$228M
5
CTVA icon
Corteva
CTVA
+$156M

Sector Composition

Rank Sector Weight
1 Technology 18.13%
2 Financials 14.48%
3 Healthcare 12.77%
4 Consumer Discretionary 9.62%
5 Industrials 8.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JAX
3276
DELISTED
J. Alexander's Holdings, Inc.
JAX
$1.42M ﹤0.01%
148,093
+6,769
+5% +$68.4K
SD icon
3277
SandRidge Energy
SD
$531M
$1.41M ﹤0.01%
333,490
-30,316
-8% -$127K
OPBK icon
3278
OP Bancorp
OPBK
$234M
$1.41M ﹤0.01%
136,182
+5,261
+4% +$51.7K
TESS
3279
DELISTED
Tessco Technologies Inc
TESS
$1.41M ﹤0.01%
125,893
-327
-0.3% -$4.15K
IDT icon
3280
IDT Corp
IDT
$1.63B
$1.41M ﹤0.01%
195,735
-20,597
-10% -$148K
ALOT icon
3281
AstroNova
ALOT
$227M
$1.41M ﹤0.01%
102,765
-1,254
-1% -$19.1K
LPL icon
3282
LG Display
LPL
$3.43B
$1.41M ﹤0.01%
203,025
+935
+0.5% +$5.81K
MAIN icon
3283
Main Street Capital
MAIN
$5.52B
$1.41M ﹤0.01%
32,680
+1,348
+4% +$57.6K
SUZ icon
3284
Suzano
SUZ
$9.66B
$1.41M ﹤0.01%
143,270
-9,676
-6% -$85.9K
SDRL
3285
DELISTED
Seadrill Limited Common Stock
SDRL
$1.41M ﹤0.01%
553,410
-871
-0.2% -$1.44K
FSLY icon
3286
Fastly Inc
FSLY
$4.58B
$1.41M ﹤0.01%
69,977
+5,211
+8% +$110K
GALT icon
3287
Galectin Therapeutics
GALT
$316M
$1.4M ﹤0.01%
490,312
+874
+0.2% +$3.04K
CTSO icon
3288
Cytosorbents Corp
CTSO
$22.6M
$1.4M ﹤0.01%
362,751
-3,059
-0.8% -$13.3K
BBU
3289
DELISTED
Brookfield Business Partners
BBU
$1.39M ﹤0.01%
52,533
-372
-0.7% -$9.65K
TWIN icon
3290
Twin Disc
TWIN
$348M
$1.39M ﹤0.01%
126,128
-573
-0.5% -$5.99K
GNE icon
3291
Genie Energy
GNE
$384M
$1.39M ﹤0.01%
179,501
-7,879
-4% -$61.7K
LOMA
3292
Loma Negra
LOMA
$1.16B
$1.38M ﹤0.01%
175,844
+17,652
+11% +$112K
RTLR
3293
DELISTED
Rattler Midstream LP Common Units
RTLR
$1.38M ﹤0.01%
77,297
+13,781
+22% +$219K
ABEO icon
3294
Abeona Therapeutics
ABEO
$422M
$1.36M ﹤0.01%
16,699
+719
+4% +$50.7K
TZOO icon
3295
Travelzoo
TZOO
$73.2M
$1.35M ﹤0.01%
126,201
+20,164
+19% +$209K
ENZ
3296
DELISTED
Enzo Biochem, Inc.
ENZ
$1.35M ﹤0.01%
513,369
-22,259
-4% -$66.5K
STRO icon
3297
Sutro Biopharma
STRO
$415M
$1.34M ﹤0.01%
12,218
+76
+0.6% +$7.83K
PCTI
3298
DELISTED
PCTEL, Inc. Common Stock
PCTI
$1.34M ﹤0.01%
158,194
+552
+0.4% +$4.58K
FSK icon
3299
FS KKR Capital
FSK
$3.39B
$1.34M ﹤0.01%
54,499
+7,171
+15% +$171K
VIR icon
3300
Vir Biotechnology
VIR
$1.51B
$1.33M ﹤0.01%
+105,752
New +$1.42M

Similar funds

Northern Trust's Q4 2019 Portfolio in Review

As of Q4 2019, Northern Trust held 4,386 positions worth $447B, up 7% from $418B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Northern Trust's Q4 2019 filing shows 134 new, 1,479 increased, 2,453 reduced and 124 closed positions. Its largest new stake was Envista: 706,517 shares worth $20.9M. The largest sale was Celgene Corp, an estimated $875M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Financials and Healthcare.

  • Northern Trust's largest Q4 2019 buy was Envista: 706,517 shares worth $20.9M.
  • Northern Trust added most to Bristol-Myers Squibb in Q4 2019, an estimated $431M increase.
  • Northern Trust's biggest Q4 2019 reduction was FlexShares Global Upstream Natural Resources Index Fund, cutting an estimated $395M.
  • Northern Trust fully exited Celgene Corp in Q4 2019, selling an estimated $875M.
  • Northern Trust's ten largest holdings make up 17% of its $447B portfolio in Q4 2019.
  • Northern Trust opened 134 new positions and closed 124 in Q4 2019.
  • Northern Trust's portfolio value rose 7% quarter-over-quarter to $447B.

Based on Northern Trust's 13F filing for Q4 2019, filed 14 Feb 2020.